25.36
Transplante de Tecidos
Transplante de tecido é um procedimento médico significativo que envolve a transferência de células, tecidos ou órgãos de um doador para um receptor,…
O transplante de tecidos é um procedimento médico complexo, mas vital, que envolve a transferência de células, tecidos ou órgãos de um doador para um receptor para restaurar as funções perdidas.
Este procedimento depende muito da presença de moléculas MHC ou HLA, que são essenciais para distinguir células 'próprias' e 'não próprias'.
Essas moléculas de MHC são únicas para cada indivíduo devido à presença de várias proteínas MHC nas células, polimorfismo do gene MHC e múltiplos alelos para cada locus MHC.
Portanto, encontrar um doador adequado cujas moléculas de MHC correspondam às do receptor é um desafio primário. Um transplante bem-sucedido requer uma correspondência entre pelo menos 3 a 4 moléculas de MHC.
Uma incompatibilidade entre as moléculas de MHC de um órgão doador e o receptor pode desencadear uma resposta citotóxica de células T, muitas vezes levando à rejeição do transplante.
Apesar de muitos desafios, o potencial terapêutico do transplante de tecidos é substancial. Por exemplo, insuficiência hepática em estágio terminal, insuficiência cardíaca ou doenças como imunodeficiência combinada grave são tratadas com sucesso por meio de transplante de órgãos.
View the full transcript and gain access to JoVE Core videos
Q1: Why are MHC molecules important in tissue transplantation?
MHC molecules are essential for distinguishing 'self' and 'non-self' cells. The immune system recognizes foreign MHC molecules on transplanted tissue and can trigger a cytotoxic T cells mediated immune response, leading to transplant rejection. Each individual has a unique set of MHC molecules due to gene polymorphism and multiple alleles, making donor-recipient matching critical for transplant success.
Q2: What does MHC polymorphism mean in the context of transplantation?
MHC polymorphism refers to the presence of multiple alleles for each MHC locus, creating vast genetic variation among individuals. Combined with polygeny—the presence of multiple MHC proteins on cells—this polymorphism makes each person's MHC profile unique. This genetic diversity is why finding a suitable donor match is extremely challenging and often requires searching worldwide databases.
Q3: How many MHC molecules must match for a successful transplant?
A successful transplant typically requires a match between at least 3–4 MHC molecules between donor and recipient. More matches are associated with increased success rates and reduced risk of rejection. However, achieving even this minimum level of matching is difficult due to the extensive polymorphisms in MHC molecules across the population.
Q4: What conditions can be treated with tissue transplantation?
Tissue transplantation treats end-stage organ failure including heart, liver, and kidney failure. Bone marrow transplants successfully address Severe Combined Immunodeficiency and leukemia. However, bone marrow transplants can cause graft-versus-host disease, where transplanted cells attack recipient tissues, leading to multiple organ damage and requiring careful management.
Q5: What is graft-versus-host disease in bone marrow transplants?
Graft-versus-host disease occurs when transplanted bone marrow cells attack the recipient's own tissues, causing damage to multiple organs. This complication represents a significant challenge in bone marrow transplantation. While efforts continue to moderate its effects, it remains an important consideration when evaluating the risks and benefits of bone marrow transplants for patients.
Q6: Why is finding a donor match so difficult in tissue transplantation?
Finding a donor match is challenging because MHC molecules exhibit both polygeny and polymorphism, creating unique profiles for each individual. The extensive genetic variation in MHC loci means compatible donors are rare. Searches often extend to worldwide databases to locate unrelated donors whose MHC molecules sufficiently match the recipient's profile.
Q7: How does the immune system respond to mismatched MHC molecules?
When donor and recipient MHC molecules mismatch, the immune system recognizes the transplanted tissue as foreign. This triggers an adaptive immune response, particularly a cytotoxic T-cell response that attacks and destroys the transplanted tissue. This immune rejection is the primary barrier to successful transplantation and is why MHC matching is so critical.